Evolving Care of Heavily Treatment–Experienced Patients With HIV

In this call between colleagues, expert faculty discuss their approaches to assessing virologic failure in a patient with an extensive but incomplete treatment history, including recommendations on assessing adherence and determining which resistance tests are needed.

Princy N. Kumar, MD, FIDSA, MACP Brian Wood, MD Physicians: maximum of 0.5 AMA PRA Category 1 Credits™ Pharmacists: 0.5 contact hours (0.05 CEUs) Released: February 22, 2021 Expired: February 21, 2022

Download this expert-authored slideset to review guidelines and key data on assessing virologic failure for patients with multiclass drug resistance.

Princy N. Kumar, MD, FIDSA, MACP Brian Wood, MD Released: February 22, 2021